NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the Un-audited Financial Results for the quarter ended June 30 2024 and declaration of Interim Dividend for FY 2024-25 if any